What You Should Know:
– One Drop has acquired all the assets and intellectual property of Sano Intelligence, Inc. which include Sano’s continuous glucose sensing platform.
– One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.
One Drop, a New York City-based provider of digital care solutions for people living with diabetes and other chronic conditions, today announced it has acquired all of the assets and intellectual property of Sano Intelligence, Inc., an innovator in health sensing technology. The deal was structured as an asset purchase, and several Sano team members will be joining One Drop.
Founded in 2011 by Ashwin Pushpala and Raj Gokal, Sano is a biometric sensor that tells you important things about your health by revealing personalized information about how your body metabolizes glucose. The almost decade of work put into developing the Sano continuous glucose sensing platform will live on in a comprehensive multi-sensorial solution from One Drop.
One Drop Integration Plans for Sano
The planned development marks a significant milestone in One Drop’s effort to bring personalized, adaptive, integrated health solutions to people in real time via their mobile phones. One Drop plans to leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.
“Sano and One Drop have a shared vision of transforming traditional healthcare into proactive, preventative self-care,” said Sano CEO and founder, Ashwin Pushpala. “We are excited to combine our sensor and device expertise with the strength of One Drop’s data-driven predictive capabilities and user-centered design to create a comprehensive collision avoidance system for health and wellness.”
One Drop’s Expanded Diabetes Solution
One Drop has expanded its diabetes solution to offer data-driven tools and personalized support for people living with type 1 diabetes, type 2 diabetes, gestational diabetes, prediabetes, high blood pressure, high cholesterol, or any combination of these conditions. At the same time, One Drop has supplemented its direct-to-consumer channels by introducing end-to-end employer and payor offerings, digital-only offerings, and broader retail availability to reach even larger populations. The company’s unique approach combines personal health coaching, connected devices, and AI-powered Predictive Insights to inspire positive behavior change.
To date, One Drop has collected 9 billion longitudinal health data points across 75 biomarkers from nearly 2.5 million users. One Drop’s continuous health sensing platform will add thousands of new data points per user per day, thereby strengthening the machine learning models behind One Drop’s predictive and adaptive support capabilities across multiple conditions.
Financial details of the acquisition were not disclosed.
